arrow
Back
L

L Price

Newcastle upon Tyne Hospitals NHS Foundation Trust

27H-index
82Paper Count
2.2KCitation Count
Published Papers 18
Publication Date
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
err2009-12-01
err97
PREAI
errSkinner, Roderick; Parry, Annie; Price, Lisa; Cole, Michael; Craft, Alan W.; Pearson, Andrew D. J.
errShare
errSave
Cyclophosphamide pharmacokinetics in children
err2008-10-29
err77
PREAI
errYule, SM; Boddy, AV; Cole, M; Price, L; Wyllie, R; Tasso, MJ; Pearson, ADJ; Idle, JR
errShare
errSave
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
err2005-04-12
err13
errOAAI
errWillits, I; Price, L; Parry, A; Tilby, MJ; Ford, D; Cholerton, S; Pearson, ADJ; Boddy, AV
errShare
errSave
Cyclophosphamide metabolism in children with non-Hodgkin's lymphoma
err2004-02-03
err42
errOAAI
errYule, SM; Price, L; McMahon, AD; Pearson, ADJ; Boddy, AV
errShare
errSave
Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokinetics
err2004-01-06
err30
errOAAI
errCole, M; Price, L; Parry, A; Keir, MJ; Pearson, ADJ; Boddy, AV; Veal, GJ
errShare
errSave
Screening girls with Turner syndrome: The National Cooperative Growth Study Experience
err2003-07-01
err18
PREAI
errParker, KL; Wyatt, DT; Blethen, SL; Baptista, J; Price, L
errShare
errSave
Nephrotoxicity in survivors of Wilms' tumours in the North of England
err2002-10-29
err39
errOAAI
errBailey, S; Roberts, A; Brock, C; Price, L; Craft, AW; Kilkarni, R; Lee, REJ; Skillen, AW; Skinner, R
errShare
errSave
Plasma coenzyme Q10 in children and adolescents undergoing doxorubicin therapy
err2000-12-01
err22
PREAI
errEaton, S; Skinner, R; Hale, JP; Pourfarzam, M; Roberts, A; Price, L; Bartlett, K
errShare
errSave
Dose-related nephrotoxicity of carboplatin in children
err1999-08-27
err58
errOAAI
errEnglish, MW; Skinner, R; Pearson, ADJ; Price, L; Wyllie, R; Craft, AW
errShare
errSave
errShare
errSave
Cisplatin dose rate as a risk factor for nephrotoxicity in children
err1998-05-01
err81
errOAAI
errSkinner, R; Pearson, ADJ; English, MW; Price, L; Wyllie, RA; Coulthard, MG; Craft, AW
errShare
errSave
errShare
errSave
Cisplatin pharmacokinetics in children with cancer
err1997-10-01
err49
PREAI
errPeng, B; English, MW; Boddy, AV; Price, L; Wyllie, R; Pearson, ADJ; Tilby, MJ; Newell, DR
errShare
errSave
The influence of ifosfamide scheduling on acute nephrotoxicity in children
err1997-05-01
err8
errOAAI
errEnglish, MW; Skinner, R; Pearson, ADJ; Price, L; Wyllie, R; Craft, AW
errShare
errSave
Risk factors for ifosfamide nephrotoxicity in children
errLANCET
IF88.5
err1996-08-01
err72
PREAI
errSkinner, R; Pearson, ADJ; English, MW; Price, L; Wyllie, RA; Coulthard, MG; Craft, AW
errShare
errSave
Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis
err1996-03-01
err32
errOAAI
errEnglish, MW; Lowis, SP; Peng, B; Boddy, A; Newell, DR; Price, L; Pearson, ADJ
errShare
errSave